(Q60368051)

English

THE USE OF PROSTATE-SPECIFIC ANTIGEN AS A SURROGATE END POINT IN THE TREATMENT OF PATIENTS WITH HORMONE REFRACTORY PROSTATE CANCER

scientific article published on 01 May 1997

Statements

The use of prostate-specific antigen as a surrogate end point in the treatment of patients with hormone refractory prostate cancer (English)
David C. Smith
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit